Literature DB >> 6127585

Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.

D R Sibley, S E Leff, I Creese.   

Abstract

The interactions of three novel dopaminergic ligands, SKF38393, SKF82526 and SKF83742, with D-1 and D-2 dopamine (DA) receptors have been investigated using radioligand binding techniques and computer modeling procedures. Using the bovine anterior pituitary D-2 DA receptor system, SKF38393 and SKF82526 behave as agonists demonstrating biphasic agonist/3H-antagonist competition curves. For both drugs, the high affinity phase comprised 30% of the total displacement curve. Such findings are atypical as previously tested classical dopamine agonists demonstrated high and low affinity displacement phases in equal proportions. Such behavior exhibited by the SKF agonists may be related to their activity as partial agonists. In contrast, SKF83742 behaves as an antagonist exhibiting homogeneous monophasic competition curves. Similar results are obtained in the rat striatal membrane D-2 DA receptor system. Both SKF38393 and SKF82526 also demonstrate shallow biphasic displacement curves on rat striatal D-1 receptors labeled with 3H-flupentixol whereas SKF83742/3H-flupentixol curves are uniphasic. Of all the ligands, only SKF38393 clearly demonstrates higher affinity for 3H-flupentixol labeled D-1 receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127585     DOI: 10.1016/0024-3205(82)90764-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons.

Authors:  Reuben Saba; Peter H Störchel; Ayla Aksoy-Aksel; Frauke Kepura; Giordano Lippi; Tim D Plant; Gerhard M Schratt
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

2.  A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory.

Authors:  Jason D Runyan; Anthony N Moore; Pramod K Dash
Journal:  Learn Mem       Date:  2005 Mar-Apr       Impact factor: 2.460

3.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

4.  Effects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons: a modeling study.

Authors:  Shang-Lin Zhou; Hong-Yuan Chu; Guo-Zhang Jin; Jian-Min Cui; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2014-05-26       Impact factor: 6.150

Review 5.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons.

Authors:  Yuriko Iwakura; Hiroyuki Nawa; Ichiro Sora; Moses V Chao
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

7.  Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.

Authors:  K Fuxe; W T O'Connor; T Antonelli; P G Osborne; S Tanganelli; L F Agnati; U Ungerstedt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Dopamine receptor turnover rates in rat striatum are age-dependent.

Authors:  S E Leff; R Gariano; I Creese
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus.

Authors:  K Starke; L Späth; J D Lang; C Adelung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

10.  Effects of dopamine, D-1 and D-2 dopaminergic agonists on the excitability of hippocampal CA1 pyramidal cells in guinea pig.

Authors:  N Berretta; F Berton; R Bianchi; M Capogna; W Francesconi; M Brunelli
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.